[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fKvG03Z9ws3XN8c0xLR_7w8EcG45aetkG_j9m54PvwDo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":86,"rows":93},"China-Japan Friendship Hospital",[4],166,false,87,1,1164628,24,136,[14,17,20,23,25,28,30,33],{"name":15,"count":16},"Chronic Obstructive Pulmonary Disease",18,{"name":18,"count":19},"Obesity",7,{"name":21,"count":22},"Bariatric Surgery",6,{"name":24,"count":22},"Pulmonary Embolism",{"name":26,"count":27},"Anemia",5,{"name":29,"count":27},"Lung Cancer",{"name":31,"count":32},"Heart Failure",4,{"name":34,"count":32},"COPD Exacerbation",[36,41,46,51,56,61,66,71,76,81],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06015165","Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery","2025-06-30","Analgesia plan for Anes. Group",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT05583773","SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction","2025-08-31","ShengXian-QuYu Decoction",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT06456749","Xishui Project for IDM of COPD and Comorbidities","2025-10-15","Integrated Disease Management",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT05540938","Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis","2025-12-31","Wangbi granules",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT06948474","Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery","2026-03-01","Dachengqi decoction",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT06173219","Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.","2026-07-31","Radiotherapy combined with immunotherapy",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT07339956","Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents","2026-08-01","A Chinese herb formula--Yiwei Jiaohuang Onitment",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT06427343","The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency","2026-09-30","High-dose ferric derisomaltose",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT06811831","Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC)","2026-10-01","Macitentan 10 mg tablet, once daily.",{"nctId":82,"briefTitle":83,"date":84,"intervention":85},"NCT07236788","Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.","2026-12-30","Iron Isomaltoside",[87,88,89,90,91,92],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[94,119,137,157,183,206,224,253,284,305,328,360,383,401,424,442,469,487,513,531,555,573,595,617,635,669,706,732,750,768,793,811,837,863,881,906,924,942,966,991,1016,1043],{"intervention":75,"totalTrials":9,"cells":95},{"EARLY_PHASE1":96,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":117},{"trials":97,"activeCount":98},[],0,{"trials":100,"activeCount":98},[],{"trials":102,"activeCount":98},[],{"trials":104,"activeCount":98},[],{"trials":106,"activeCount":9,"soonestReadout":74},[107],{"nctId":72,"briefTitle":73,"status":108,"phases":109,"primaryCompletion":74,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":115},"RECRUITING",[91],"2026-12-21","2023-10-01",114,[31,114],"Iron Deficiency",[75,116],"Low-dose ferric derisomaltose",{"trials":118,"activeCount":98},[],{"intervention":116,"totalTrials":9,"cells":120},{"EARLY_PHASE1":121,"PHASE1":123,"PHASE2":125,"PHASE3":127,"PHASE4":129,"NA":135},{"trials":122,"activeCount":98},[],{"trials":124,"activeCount":98},[],{"trials":126,"activeCount":98},[],{"trials":128,"activeCount":98},[],{"trials":130,"activeCount":9,"soonestReadout":74},[131],{"nctId":72,"briefTitle":73,"status":108,"phases":132,"primaryCompletion":74,"completion":110,"start":111,"enrollment":112,"conditions":133,"interventions":134},[91],[31,114],[75,116],{"trials":136,"activeCount":98},[],{"intervention":45,"totalTrials":9,"cells":138},{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":143,"PHASE3":145,"PHASE4":147,"NA":155},{"trials":140,"activeCount":98},[],{"trials":142,"activeCount":98},[],{"trials":144,"activeCount":98},[],{"trials":146,"activeCount":98},[],{"trials":148,"activeCount":9,"soonestReadout":44},[149],{"nctId":42,"briefTitle":43,"status":108,"phases":150,"primaryCompletion":44,"completion":54,"start":151,"enrollment":152,"conditions":153,"interventions":154},[91],"2023-03-29",336,[31],[45],{"trials":156,"activeCount":98},[],{"intervention":158,"totalTrials":9,"cells":159},"Kuangxiong Aerosol",{"EARLY_PHASE1":160,"PHASE1":162,"PHASE2":164,"PHASE3":166,"PHASE4":168,"NA":181},{"trials":161,"activeCount":98},[],{"trials":163,"activeCount":98},[],{"trials":165,"activeCount":98},[],{"trials":167,"activeCount":98},[],{"trials":169,"activeCount":9,"soonestReadout":175},[170],{"nctId":171,"briefTitle":172,"status":173,"phases":174,"primaryCompletion":175,"completion":175,"start":176,"enrollment":177,"conditions":178,"interventions":180},"NCT06901570","Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease","NOT_YET_RECRUITING",[91],"2028-07","2025-04",528,[179],"Coronary Microvascular Disease",[158],{"trials":182,"activeCount":98},[],{"intervention":55,"totalTrials":9,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":193,"NA":204},{"trials":186,"activeCount":98},[],{"trials":188,"activeCount":98},[],{"trials":190,"activeCount":98},[],{"trials":192,"activeCount":98},[],{"trials":194,"activeCount":9,"soonestReadout":54},[195],{"nctId":52,"briefTitle":53,"status":108,"phases":196,"primaryCompletion":54,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":202},[91],"2026-03-31","2023-05-23",340,[201],"Rheumatoid Arthritis",[55,203],"Wangbi granules simulant",{"trials":205,"activeCount":98},[],{"intervention":203,"totalTrials":9,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":222},{"trials":209,"activeCount":98},[],{"trials":211,"activeCount":98},[],{"trials":213,"activeCount":98},[],{"trials":215,"activeCount":98},[],{"trials":217,"activeCount":9,"soonestReadout":54},[218],{"nctId":52,"briefTitle":53,"status":108,"phases":219,"primaryCompletion":54,"completion":197,"start":198,"enrollment":199,"conditions":220,"interventions":221},[91],[201],[55,203],{"trials":223,"activeCount":98},[],{"intervention":225,"totalTrials":9,"cells":226},"semaglutide",{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":251},{"trials":228,"activeCount":98},[],{"trials":230,"activeCount":98},[],{"trials":232,"activeCount":98},[],{"trials":234,"activeCount":98},[],{"trials":236,"activeCount":9,"soonestReadout":242},[237],{"nctId":238,"briefTitle":239,"status":240,"phases":241,"primaryCompletion":242,"completion":242,"start":243,"enrollment":244,"conditions":245,"interventions":249},"NCT06959784","Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)","ENROLLING_BY_INVITATION",[91],"2026-12-31","2024-01-01",142,[246,247,248],"Diabetes Mellitus","Cardiovascular Diseases","Cerebrovascular Disease",[225,250],"Metformin",{"trials":252,"activeCount":98},[],{"intervention":250,"totalTrials":254,"cells":255},2,{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":270},{"trials":257,"activeCount":98},[],{"trials":259,"activeCount":98},[],{"trials":261,"activeCount":98},[],{"trials":263,"activeCount":98},[],{"trials":265,"activeCount":9,"soonestReadout":242},[266],{"nctId":238,"briefTitle":239,"status":240,"phases":267,"primaryCompletion":242,"completion":242,"start":243,"enrollment":244,"conditions":268,"interventions":269},[91],[246,247,248],[225,250],{"trials":271,"activeCount":98},[272],{"nctId":273,"briefTitle":274,"status":275,"phases":276,"primaryCompletion":277,"completion":277,"start":278,"enrollment":279,"conditions":280,"interventions":282},"NCT01342614","The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension","COMPLETED",[92],"2009-08","2006-05",140,[246,281],"Essential Hypertension",[283,250],"Fosinopril",{"intervention":65,"totalTrials":9,"cells":285},{"EARLY_PHASE1":286,"PHASE1":288,"PHASE2":290,"PHASE3":299,"PHASE4":301,"NA":303},{"trials":287,"activeCount":98},[],{"trials":289,"activeCount":98},[],{"trials":291,"activeCount":9,"soonestReadout":64},[292],{"nctId":62,"briefTitle":63,"status":108,"phases":293,"primaryCompletion":64,"completion":242,"start":294,"enrollment":295,"conditions":296,"interventions":298},[88,89],"2025-08-01",38,[297],"Advanced Solid Tumor",[65],{"trials":300,"activeCount":98},[],{"trials":302,"activeCount":98},[],{"trials":304,"activeCount":98},[],{"intervention":306,"totalTrials":9,"cells":307},"BS-GLP group",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":322,"PHASE4":324,"NA":326},{"trials":309,"activeCount":98},[],{"trials":311,"activeCount":98},[],{"trials":313,"activeCount":9,"soonestReadout":318},[314],{"nctId":315,"briefTitle":316,"status":108,"phases":317,"primaryCompletion":318,"completion":318,"start":243,"enrollment":319,"conditions":320,"interventions":321},"NCT07336862","Bariatric Surgery Combined With GLP-1 Receptor Agonists Study",[88,89],"2027-12",200,[18],[306],{"trials":323,"activeCount":98},[],{"trials":325,"activeCount":98},[],{"trials":327,"activeCount":98},[],{"intervention":80,"totalTrials":254,"cells":329},{"EARLY_PHASE1":330,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":356,"NA":358},{"trials":331,"activeCount":254,"soonestReadout":79},[332,340],{"nctId":77,"briefTitle":78,"status":108,"phases":333,"primaryCompletion":79,"completion":79,"start":334,"enrollment":335,"conditions":336,"interventions":339},[87],"2024-11-01",30,[337,338],"Coronary Microvascular Angina","Macitentan",[80],{"nctId":341,"briefTitle":342,"status":108,"phases":343,"primaryCompletion":344,"completion":344,"start":345,"enrollment":346,"conditions":347,"interventions":349},"NCT07392281","Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina",[87],"2027-08-31","2025-09-01",40,[348],"Non-Coronary Obstructive Angina",[80],{"trials":351,"activeCount":98},[],{"trials":353,"activeCount":98},[],{"trials":355,"activeCount":98},[],{"trials":357,"activeCount":98},[],{"trials":359,"activeCount":98},[],{"intervention":70,"totalTrials":9,"cells":361},{"EARLY_PHASE1":362,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":379,"NA":381},{"trials":363,"activeCount":9,"soonestReadout":69},[364],{"nctId":67,"briefTitle":68,"status":173,"phases":365,"primaryCompletion":69,"completion":366,"start":367,"enrollment":368,"conditions":369,"interventions":371},[87],"2026-08-30","2026-01-10",60,[370],"Gastrointestinal Bleeding",[70,372],"Rabeprazole Enteric-Coated",{"trials":374,"activeCount":98},[],{"trials":376,"activeCount":98},[],{"trials":378,"activeCount":98},[],{"trials":380,"activeCount":98},[],{"trials":382,"activeCount":98},[],{"intervention":372,"totalTrials":9,"cells":384},{"EARLY_PHASE1":385,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":399},{"trials":386,"activeCount":9,"soonestReadout":69},[387],{"nctId":67,"briefTitle":68,"status":173,"phases":388,"primaryCompletion":69,"completion":366,"start":367,"enrollment":368,"conditions":389,"interventions":390},[87],[370],[70,372],{"trials":392,"activeCount":98},[],{"trials":394,"activeCount":98},[],{"trials":396,"activeCount":98},[],{"trials":398,"activeCount":98},[],{"trials":400,"activeCount":98},[],{"intervention":40,"totalTrials":9,"cells":402},{"EARLY_PHASE1":403,"PHASE1":405,"PHASE2":407,"PHASE3":409,"PHASE4":411,"NA":413},{"trials":404,"activeCount":98},[],{"trials":406,"activeCount":98},[],{"trials":408,"activeCount":98},[],{"trials":410,"activeCount":98},[],{"trials":412,"activeCount":98},[],{"trials":414,"activeCount":9,"soonestReadout":39},[415],{"nctId":37,"briefTitle":38,"status":108,"phases":416,"primaryCompletion":39,"completion":417,"start":418,"enrollment":419,"conditions":420,"interventions":422},[92],"2025-10-10","2024-09-10",216,[421],"Postoperative Pain",[40,423],"Analgesia plan for Surg. Group",{"intervention":423,"totalTrials":9,"cells":425},{"EARLY_PHASE1":426,"PHASE1":428,"PHASE2":430,"PHASE3":432,"PHASE4":434,"NA":436},{"trials":427,"activeCount":98},[],{"trials":429,"activeCount":98},[],{"trials":431,"activeCount":98},[],{"trials":433,"activeCount":98},[],{"trials":435,"activeCount":98},[],{"trials":437,"activeCount":9,"soonestReadout":39},[438],{"nctId":37,"briefTitle":38,"status":108,"phases":439,"primaryCompletion":39,"completion":417,"start":418,"enrollment":419,"conditions":440,"interventions":441},[92],[421],[40,423],{"intervention":443,"totalTrials":9,"cells":444},"JAK Inhibitor",{"EARLY_PHASE1":445,"PHASE1":447,"PHASE2":449,"PHASE3":451,"PHASE4":453,"NA":455},{"trials":446,"activeCount":98},[],{"trials":448,"activeCount":98},[],{"trials":450,"activeCount":98},[],{"trials":452,"activeCount":98},[],{"trials":454,"activeCount":98},[],{"trials":456,"activeCount":9,"soonestReadout":461},[457],{"nctId":458,"briefTitle":459,"status":173,"phases":460,"primaryCompletion":461,"completion":461,"start":462,"enrollment":463,"conditions":464,"interventions":467},"NCT07406932","A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome",[92],"2027-07-01","2026-02-01",80,[465,466],"Antisynthetase Syndrome","Interstitial Lung Disease (ILD)",[443,468],"Calcineurin Inhibitors",{"intervention":468,"totalTrials":9,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":479,"NA":481},{"trials":472,"activeCount":98},[],{"trials":474,"activeCount":98},[],{"trials":476,"activeCount":98},[],{"trials":478,"activeCount":98},[],{"trials":480,"activeCount":98},[],{"trials":482,"activeCount":9,"soonestReadout":461},[483],{"nctId":458,"briefTitle":459,"status":173,"phases":484,"primaryCompletion":461,"completion":461,"start":462,"enrollment":463,"conditions":485,"interventions":486},[92],[465,466],[443,468],{"intervention":488,"totalTrials":9,"cells":489},"Yiqi Yangyin Formula",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":496,"PHASE4":498,"NA":500},{"trials":491,"activeCount":98},[],{"trials":493,"activeCount":98},[],{"trials":495,"activeCount":98},[],{"trials":497,"activeCount":98},[],{"trials":499,"activeCount":98},[],{"trials":501,"activeCount":9,"soonestReadout":506},[502],{"nctId":503,"briefTitle":504,"status":173,"phases":505,"primaryCompletion":506,"completion":507,"start":345,"enrollment":508,"conditions":509,"interventions":511},"NCT07145060","A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome",[92],"2028-01-31","2028-03-31",105,[510],"Primary Sjögren's Syndrome (pSS)",[488,512],"Yiqi Yangyin Formula placebo",{"intervention":512,"totalTrials":9,"cells":514},{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":523,"NA":525},{"trials":516,"activeCount":98},[],{"trials":518,"activeCount":98},[],{"trials":520,"activeCount":98},[],{"trials":522,"activeCount":98},[],{"trials":524,"activeCount":98},[],{"trials":526,"activeCount":9,"soonestReadout":506},[527],{"nctId":503,"briefTitle":504,"status":173,"phases":528,"primaryCompletion":506,"completion":507,"start":345,"enrollment":508,"conditions":529,"interventions":530},[92],[510],[488,512],{"intervention":60,"totalTrials":9,"cells":532},{"EARLY_PHASE1":533,"PHASE1":535,"PHASE2":537,"PHASE3":539,"PHASE4":541,"NA":543},{"trials":534,"activeCount":98},[],{"trials":536,"activeCount":98},[],{"trials":538,"activeCount":98},[],{"trials":540,"activeCount":98},[],{"trials":542,"activeCount":98},[],{"trials":544,"activeCount":9,"soonestReadout":59},[545],{"nctId":57,"briefTitle":58,"status":546,"phases":547,"primaryCompletion":59,"completion":548,"start":549,"enrollment":550,"conditions":551,"interventions":553},"ACTIVE_NOT_RECRUITING",[92],"2026-06-01","2024-08-01",45,[552],"Whipple Operation",[60,554],"Normal Saline",{"intervention":554,"totalTrials":9,"cells":556},{"EARLY_PHASE1":557,"PHASE1":559,"PHASE2":561,"PHASE3":563,"PHASE4":565,"NA":567},{"trials":558,"activeCount":98},[],{"trials":560,"activeCount":98},[],{"trials":562,"activeCount":98},[],{"trials":564,"activeCount":98},[],{"trials":566,"activeCount":98},[],{"trials":568,"activeCount":9,"soonestReadout":59},[569],{"nctId":57,"briefTitle":58,"status":546,"phases":570,"primaryCompletion":59,"completion":548,"start":549,"enrollment":550,"conditions":571,"interventions":572},[92],[552],[60,554],{"intervention":50,"totalTrials":9,"cells":574},{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":581,"PHASE4":583,"NA":585},{"trials":576,"activeCount":98},[],{"trials":578,"activeCount":98},[],{"trials":580,"activeCount":98},[],{"trials":582,"activeCount":98},[],{"trials":584,"activeCount":98},[],{"trials":586,"activeCount":9,"soonestReadout":49},[587],{"nctId":47,"briefTitle":48,"status":173,"phases":588,"primaryCompletion":49,"completion":589,"start":590,"enrollment":591,"conditions":592,"interventions":594},[],"2026-03-15","2024-06-17",4000,[15,593],"Comorbidities and Coexisting Conditions",[50],{"intervention":85,"totalTrials":9,"cells":596},{"EARLY_PHASE1":597,"PHASE1":599,"PHASE2":601,"PHASE3":603,"PHASE4":605,"NA":607},{"trials":598,"activeCount":98},[],{"trials":600,"activeCount":98},[],{"trials":602,"activeCount":98},[],{"trials":604,"activeCount":98},[],{"trials":606,"activeCount":98},[],{"trials":608,"activeCount":9,"soonestReadout":84},[609],{"nctId":82,"briefTitle":83,"status":108,"phases":610,"primaryCompletion":84,"completion":611,"start":612,"enrollment":319,"conditions":613,"interventions":615},[92],"2027-03-30","2025-03-01",[18,26,614,21],"Iron Deficiencies",[85,616],"Physiological saline solution",{"intervention":616,"totalTrials":9,"cells":618},{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":627,"NA":629},{"trials":620,"activeCount":98},[],{"trials":622,"activeCount":98},[],{"trials":624,"activeCount":98},[],{"trials":626,"activeCount":98},[],{"trials":628,"activeCount":98},[],{"trials":630,"activeCount":9,"soonestReadout":84},[631],{"nctId":82,"briefTitle":83,"status":108,"phases":632,"primaryCompletion":84,"completion":611,"start":612,"enrollment":319,"conditions":633,"interventions":634},[92],[18,26,614,21],[85,616],{"intervention":636,"totalTrials":254,"cells":637},"Ferric derisomaltose",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":644,"PHASE4":646,"NA":667},{"trials":639,"activeCount":98},[],{"trials":641,"activeCount":98},[],{"trials":643,"activeCount":98},[],{"trials":645,"activeCount":98},[],{"trials":647,"activeCount":98},[648,659],{"nctId":649,"briefTitle":650,"status":651,"phases":652,"primaryCompletion":549,"completion":294,"start":653,"enrollment":654,"conditions":655,"interventions":658},"NCT05971732","The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)","UNKNOWN",[91],"2023-08-01",146,[656,114,657],"Heart Failure With Reduced Ejection Fraction","Acute Heart Failure",[636],{"nctId":660,"briefTitle":661,"status":651,"phases":662,"primaryCompletion":549,"completion":294,"start":653,"enrollment":663,"conditions":664,"interventions":666},"NCT05991128","The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life",[91],170,[665,614,657],"Heart Failure With Preserved Ejection Fraction",[636],{"trials":668,"activeCount":98},[],{"intervention":670,"totalTrials":254,"cells":671},"Test preparation：Methylcholine chloroacetate for inhalation",{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":676,"PHASE3":678,"PHASE4":680,"NA":704},{"trials":673,"activeCount":98},[],{"trials":675,"activeCount":98},[],{"trials":677,"activeCount":98},[],{"trials":679,"activeCount":98},[],{"trials":681,"activeCount":98},[682,693],{"nctId":683,"briefTitle":684,"status":275,"phases":685,"primaryCompletion":686,"completion":687,"start":688,"enrollment":346,"conditions":689,"interventions":691},"NCT06725641","Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)",[91],"2024-10-22","2024-10-26","2024-02-24",[690],"Asthma",[670,692],"Reference preparation：Methylcholine chloroacetate for inhalation（Provocholine）",{"nctId":694,"briefTitle":695,"status":275,"phases":696,"primaryCompletion":697,"completion":697,"start":698,"enrollment":699,"conditions":700,"interventions":702},"NCT06730620","Bioequivalence Study of Methacholine Chloride",[91],"2024-02-03","2024-01-29",20,[701],"Healthy People",[670,703],"Reference preparation：Methylcholine chloroacetate for inhalation（(Provocholin）",{"trials":705,"activeCount":98},[],{"intervention":707,"totalTrials":9,"cells":708},"Roxadustat",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":730},{"trials":710,"activeCount":98},[],{"trials":712,"activeCount":98},[],{"trials":714,"activeCount":98},[],{"trials":716,"activeCount":98},[],{"trials":718,"activeCount":98},[719],{"nctId":720,"briefTitle":721,"status":651,"phases":722,"primaryCompletion":653,"completion":723,"start":724,"enrollment":725,"conditions":726,"interventions":728},"NCT05691257","Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia",[91],"2023-12-01","2023-02-01",300,[31,727,26],"Chronic Kidney Diseases",[707,729],"Recombinant human eythropoietin and\u002For Iron agents",{"trials":731,"activeCount":98},[],{"intervention":729,"totalTrials":9,"cells":733},{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":740,"PHASE4":742,"NA":748},{"trials":735,"activeCount":98},[],{"trials":737,"activeCount":98},[],{"trials":739,"activeCount":98},[],{"trials":741,"activeCount":98},[],{"trials":743,"activeCount":98},[744],{"nctId":720,"briefTitle":721,"status":651,"phases":745,"primaryCompletion":653,"completion":723,"start":724,"enrollment":725,"conditions":746,"interventions":747},[91],[31,727,26],[707,729],{"trials":749,"activeCount":98},[],{"intervention":692,"totalTrials":9,"cells":751},{"EARLY_PHASE1":752,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":760,"NA":766},{"trials":753,"activeCount":98},[],{"trials":755,"activeCount":98},[],{"trials":757,"activeCount":98},[],{"trials":759,"activeCount":98},[],{"trials":761,"activeCount":98},[762],{"nctId":683,"briefTitle":684,"status":275,"phases":763,"primaryCompletion":686,"completion":687,"start":688,"enrollment":346,"conditions":764,"interventions":765},[91],[690],[670,692],{"trials":767,"activeCount":98},[],{"intervention":769,"totalTrials":9,"cells":770},"Succinylcholine",{"EARLY_PHASE1":771,"PHASE1":773,"PHASE2":775,"PHASE3":777,"PHASE4":779,"NA":791},{"trials":772,"activeCount":98},[],{"trials":774,"activeCount":98},[],{"trials":776,"activeCount":98},[],{"trials":778,"activeCount":98},[],{"trials":780,"activeCount":98},[781],{"nctId":782,"briefTitle":783,"status":275,"phases":784,"primaryCompletion":785,"completion":785,"start":786,"enrollment":787,"conditions":788,"interventions":790},"NCT05556408","High-Resolution Solid-State Manometry of the Effect of Succinylcholine on Barrier Pressure",[91],"2015-12-30","2015-03-01",14,[789],"the Effect of Succinylcholine on Barrier Pressure",[769],{"trials":792,"activeCount":98},[],{"intervention":703,"totalTrials":9,"cells":794},{"EARLY_PHASE1":795,"PHASE1":797,"PHASE2":799,"PHASE3":801,"PHASE4":803,"NA":809},{"trials":796,"activeCount":98},[],{"trials":798,"activeCount":98},[],{"trials":800,"activeCount":98},[],{"trials":802,"activeCount":98},[],{"trials":804,"activeCount":98},[805],{"nctId":694,"briefTitle":695,"status":275,"phases":806,"primaryCompletion":697,"completion":697,"start":698,"enrollment":699,"conditions":807,"interventions":808},[91],[701],[670,703],{"trials":810,"activeCount":98},[],{"intervention":812,"totalTrials":9,"cells":813},"Traditional Chinese Medicine Formula LC09",{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":820,"PHASE4":833,"NA":835},{"trials":815,"activeCount":98},[],{"trials":817,"activeCount":98},[],{"trials":819,"activeCount":98},[],{"trials":821,"activeCount":98},[822],{"nctId":823,"briefTitle":824,"status":275,"phases":825,"primaryCompletion":826,"completion":827,"start":828,"enrollment":829,"conditions":830,"interventions":832},"NCT02794493","Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and\u002For Breast Cancer",[90],"2017-12-31","2018-04-25","2015-04-01",156,[831],"Hand Foot Syndrome",[812],{"trials":834,"activeCount":98},[],{"trials":836,"activeCount":98},[],{"intervention":838,"totalTrials":9,"cells":839},"Shugan Dingtong decoction",{"EARLY_PHASE1":840,"PHASE1":853,"PHASE2":855,"PHASE3":857,"PHASE4":859,"NA":861},{"trials":841,"activeCount":98},[842],{"nctId":843,"briefTitle":844,"status":275,"phases":845,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":849,"interventions":851},"NCT05508516","Shugan Dingtong Decoction in the Treatment of Fibromyalgia",[87],"2024-10-18","2022-09-01",72,[850],"Fibromyalgia",[838,852],"Duloxetine Hydrochloride",{"trials":854,"activeCount":98},[],{"trials":856,"activeCount":98},[],{"trials":858,"activeCount":98},[],{"trials":860,"activeCount":98},[],{"trials":862,"activeCount":98},[],{"intervention":852,"totalTrials":9,"cells":864},{"EARLY_PHASE1":865,"PHASE1":871,"PHASE2":873,"PHASE3":875,"PHASE4":877,"NA":879},{"trials":866,"activeCount":98},[867],{"nctId":843,"briefTitle":844,"status":275,"phases":868,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":869,"interventions":870},[87],[850],[838,852],{"trials":872,"activeCount":98},[],{"trials":874,"activeCount":98},[],{"trials":876,"activeCount":98},[],{"trials":878,"activeCount":98},[],{"trials":880,"activeCount":98},[],{"intervention":882,"totalTrials":9,"cells":883},"Tranexamic Acid；",{"EARLY_PHASE1":884,"PHASE1":896,"PHASE2":898,"PHASE3":900,"PHASE4":902,"NA":904},{"trials":885,"activeCount":98},[886],{"nctId":887,"briefTitle":888,"status":651,"phases":889,"primaryCompletion":890,"completion":890,"start":723,"enrollment":725,"conditions":891,"interventions":893},"NCT06149091","Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase",[87],"2024-12-31",[892],"Iatrogenic Endobronchial Bleeding",[882,894,895],"Adrenalin","Hemagglutinase",{"trials":897,"activeCount":98},[],{"trials":899,"activeCount":98},[],{"trials":901,"activeCount":98},[],{"trials":903,"activeCount":98},[],{"trials":905,"activeCount":98},[],{"intervention":894,"totalTrials":9,"cells":907},{"EARLY_PHASE1":908,"PHASE1":914,"PHASE2":916,"PHASE3":918,"PHASE4":920,"NA":922},{"trials":909,"activeCount":98},[910],{"nctId":887,"briefTitle":888,"status":651,"phases":911,"primaryCompletion":890,"completion":890,"start":723,"enrollment":725,"conditions":912,"interventions":913},[87],[892],[882,894,895],{"trials":915,"activeCount":98},[],{"trials":917,"activeCount":98},[],{"trials":919,"activeCount":98},[],{"trials":921,"activeCount":98},[],{"trials":923,"activeCount":98},[],{"intervention":895,"totalTrials":9,"cells":925},{"EARLY_PHASE1":926,"PHASE1":932,"PHASE2":934,"PHASE3":936,"PHASE4":938,"NA":940},{"trials":927,"activeCount":98},[928],{"nctId":887,"briefTitle":888,"status":651,"phases":929,"primaryCompletion":890,"completion":890,"start":723,"enrollment":725,"conditions":930,"interventions":931},[87],[892],[882,894,895],{"trials":933,"activeCount":98},[],{"trials":935,"activeCount":98},[],{"trials":937,"activeCount":98},[],{"trials":939,"activeCount":98},[],{"trials":941,"activeCount":98},[],{"intervention":943,"totalTrials":9,"cells":944},"Dexamethasone oral",{"EARLY_PHASE1":945,"PHASE1":947,"PHASE2":949,"PHASE3":951,"PHASE4":953,"NA":955},{"trials":946,"activeCount":98},[],{"trials":948,"activeCount":98},[],{"trials":950,"activeCount":98},[],{"trials":952,"activeCount":98},[],{"trials":954,"activeCount":98},[],{"trials":956,"activeCount":98},[957],{"nctId":958,"briefTitle":959,"status":651,"phases":960,"primaryCompletion":890,"completion":890,"start":961,"enrollment":962,"conditions":963,"interventions":965},"NCT05798195","Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia",[92],"2023-01-01",420,[964],"COVID-19 Pneumonia",[943],{"intervention":967,"totalTrials":9,"cells":968},"Digital Intervention",{"EARLY_PHASE1":969,"PHASE1":971,"PHASE2":973,"PHASE3":975,"PHASE4":977,"NA":979},{"trials":970,"activeCount":98},[],{"trials":972,"activeCount":98},[],{"trials":974,"activeCount":98},[],{"trials":976,"activeCount":98},[],{"trials":978,"activeCount":98},[],{"trials":980,"activeCount":98},[981],{"nctId":982,"briefTitle":983,"status":651,"phases":984,"primaryCompletion":985,"completion":986,"start":987,"enrollment":988,"conditions":989,"interventions":990},"NCT05667363","Digital Therapeutics on Inhalation Medication Adherence in COPD",[92],"2023-05-01","2023-09-01","2022-12-20",582,[15],[967],{"intervention":992,"totalTrials":9,"cells":993},"Rivaroxaban",{"EARLY_PHASE1":994,"PHASE1":996,"PHASE2":998,"PHASE3":1000,"PHASE4":1002,"NA":1004},{"trials":995,"activeCount":98},[],{"trials":997,"activeCount":98},[],{"trials":999,"activeCount":98},[],{"trials":1001,"activeCount":98},[],{"trials":1003,"activeCount":98},[],{"trials":1005,"activeCount":98},[1006],{"nctId":1007,"briefTitle":1008,"status":651,"phases":1009,"primaryCompletion":1010,"completion":1011,"start":1012,"enrollment":1013,"conditions":1014,"interventions":1015},"NCT04527042","Effectiveness and Safety of Rivaroxaban Used in Extended Anticoagulation for Pulmonary Embolism Patients",[],"2022-11-29","2024-05-30","2020-11-30",496,[24],[992],{"intervention":1017,"totalTrials":9,"cells":1018},"Spleen Invigorating and Weight Reducing Decoction",{"EARLY_PHASE1":1019,"PHASE1":1021,"PHASE2":1023,"PHASE3":1025,"PHASE4":1027,"NA":1029},{"trials":1020,"activeCount":98},[],{"trials":1022,"activeCount":98},[],{"trials":1024,"activeCount":98},[],{"trials":1026,"activeCount":98},[],{"trials":1028,"activeCount":98},[],{"trials":1030,"activeCount":98},[1031],{"nctId":1032,"briefTitle":1033,"status":651,"phases":1034,"primaryCompletion":1035,"completion":1036,"start":1037,"enrollment":1038,"conditions":1039,"interventions":1042},"NCT06419764","Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery",[92],"2024-07","2025-07","2024-02-01",120,[1040,1041],"Traditional Chinese Medicine Treatment","Weight Change",[1017],{"intervention":283,"totalTrials":9,"cells":1044},{"EARLY_PHASE1":1045,"PHASE1":1047,"PHASE2":1049,"PHASE3":1051,"PHASE4":1053,"NA":1055},{"trials":1046,"activeCount":98},[],{"trials":1048,"activeCount":98},[],{"trials":1050,"activeCount":98},[],{"trials":1052,"activeCount":98},[],{"trials":1054,"activeCount":98},[],{"trials":1056,"activeCount":98},[1057],{"nctId":273,"briefTitle":274,"status":275,"phases":1058,"primaryCompletion":277,"completion":277,"start":278,"enrollment":279,"conditions":1059,"interventions":1060},[92],[246,281],[283,250]]